Target intelligence / Profile preview

Tissue fragmentation via ultrasonic cavitation

Molecular classification
Other (physical process; not a molecule, receptor, enzyme, transporter, etc.)
01

Overview

Tissue fragmentation via ultrasonic cavitation refers to the use of high-frequency ultrasound energy to disrupt biological tissue through the formation, oscillation, and collapse of microbubbles, a phenomenon known as cavitation. These bubbles produce physical forces that fragment tissue at the cellular level, selectively damaging targets like adipocytes in body contouring/liposuction, destroying atherosclerotic plaques, or ablating tumors[1][3][8]. The process is mediated by mechanical (cavitation), thermal (heat), and chemical (free radical generation) effects, with device parameters fine-tuned to target specific tissues while minimizing collateral damage. It is widely used in ultrasonic liposuction, surgical aspirators, and focused ultrasound therapies, but is not a molecular or receptor-based target; it is a physical-chemical method for tissue ablation[5][7][8]. Notable safety concerns include risk of burns, seroma formation, and DNA damage from free radicals[4][7].

Other names
Ultrasonic tissue fragmentationUltrasound-assisted tissue ablationCavitation-mediated tissue disruptionUltrasonic surgical aspirator process
02

Mechanism of action

Mechanical disruption via cavitation; Cell membrane fragmentation; Implosion of fat cells (adipocytes); Generation of reactive oxygen species (ROS) and free radicals

03

Biological functions

Tissue ablationCell destructionFat cell lysisCollagen fragmentationApoptosis induction through mechanical force and free radical generation
04

Disease associations

Atherosclerosis/plaque disruptionAdipose tissue reduction (body contouring/liposuction)Tumor ablationOther tissue-removal surgeries
05

Safety considerations

Thermal injury/burnsSeroma formation (fluid accumulation)Collateral damage to surrounding tissuesGeneration of free radicals and DNA damageDevascularization injury in thin tissue areasNon-specific tissue destruction with excessive exposure
06

Biomarkers

None specific to the "target"; outcome markers may include extent of tissue disrupted, lipid profile post-ablation, or histology of ablated area

Beyond the preview

Go deeper on Tissue fragmentation via ultrasonic cavitation.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tissue fragmentation via ultrasonic cavitation.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call